|34.17||+0.4700||+1.39%||Vol 307.35K||1Y Perf 232.80%|
|Apr 16th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||52.14||Analyst Rating||Strong Buy 1.00|
|Potential %||52.59||Finscreener Ranking||★★★★★ 64.22|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 60.73|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 63.53|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||1.14B||Earnings Rating||Buy|
|Price Range Ratio 52W %||63.66||Earnings Date||13th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|5 Years||1 727.27%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||13th May 2021|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||10.00|
|Avg. Weekly Volume||234.74K|
|Avg. Monthly Volume||421.31K|
|Avg. Quarterly Volume||307.57K|
BioLife Solutions Inc. (NASDAQ: BLFS) stock closed at 34.17 per share at the end of the most recent trading day (a 1.39% change compared to the prior day closing price) with a volume of 307.80K shares and market capitalization of 1.14B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 158 people. BioLife Solutions Inc. CEO is Michael Rice.
The one-year performance of BioLife Solutions Inc. stock is 232.8%, while year-to-date (YTD) performance is -14.34%. BLFS stock has a five-year performance of 1727.27%. Its 52-week range is between 10 and 47.97, which gives BLFS stock a 52-week price range ratio of 63.66%
BioLife Solutions Inc. currently has a PE ratio of -45.30, a price-to-book (PB) ratio of 5.83, a price-to-sale (PS) ratio of 32.36, a price to cashflow ratio of 147.10, a PEG ratio of 2.32, a ROA of 1.59%, a ROC of 5.41% and a ROE of 2.11%. The company’s profit margin is -63.72%, its EBITDA margin is 3.60%, and its revenue ttm is $35.93 Million , which makes it $1.08 revenue per share.
Of the last four earnings reports from BioLife Solutions Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioLife Solutions Inc.’s next earnings report date is 13th May 2021.
The consensus rating of Wall Street analysts for BioLife Solutions Inc. is Strong Buy (1), with a target price of $52.14, which is +52.59% compared to the current price. The earnings rating for BioLife Solutions Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
BioLife Solutions Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
BioLife Solutions Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.22, ATR14 : 2.44, CCI20 : -119.30, Chaikin Money Flow : -0.19, MACD : -1.82, Money Flow Index : 59.37, ROC : -4.98, RSI : 37.38, STOCH (14,3) : 30.36, STOCH RSI : 0.75, UO : 40.18, Williams %R : -69.64), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of BioLife Solutions Inc. in the last 12-months were: Aby J. Mathew (Option Excercise at a value of $218 561), Aby J. Mathew (Sold 186 960 shares of value $5 289 704 ), Andrew G. Hinson (Sold 5 000 shares of value $207 475 ), James Mathers (Sold 242 shares of value $4 083 ), Joseph Schick (Option Excercise at a value of $9 500), Joseph Schick (Sold 6 250 shares of value $207 000 ), Karen Foster (Option Excercise at a value of $53 572), Karen Foster (Sold 48 004 shares of value $1 849 446 ), Marcus Schulz (Sold 9 516 shares of value $339 690 ), Michael Rice (Option Excercise at a value of $538 684), Michael Rice (Sold 318 906 shares of value $7 839 068 ), Raymond Wayne Cohen (Sold 5 625 shares of value $182 531 ), Roderick De Greef (Option Excercise at a value of $107 100), Roderick De Greef (Sold 79 089 shares of value $2 893 446 ), Thomas Girschweiler (Option Excercise at a value of $14 669 842), Thomas Girschweiler (Sold 5 748 102 shares of value $105 531 770 ), Todd Berard (Option Excercise at a value of $63 076), Todd Berard (Sold 44 877 shares of value $1 713 104 ), Walter Villiger (Option Excercise at a value of $9 404 252), Walter Villiger (Sold 2 261 614 shares of value $61 763 331 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.